{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:51:05Z","timestamp":1719928265753},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.prp.2010.10.009","type":"journal-article","created":{"date-parts":[[2010,12,24]],"date-time":"2010-12-24T09:33:14Z","timestamp":1293183194000},"page":"97-103","source":"Crossref","is-referenced-by-count":8,"title":["Expression of proteoglycan versican in in situ breast lesions: Relations between stromal changes, histotype, and invasion"],"prefix":"10.1016","volume":"207","author":[{"given":"G.","family":"Canavese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Candelaresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Mano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"July (7)","key":"10.1016\/j.prp.2010.10.009_bib0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.cr.7290318","article-title":"The interaction of versican with its binding partners","volume":"15","author":"Wu","year":"2005","journal-title":"Cell Res."},{"issue":"October (5)","key":"10.1016\/j.prp.2010.10.009_bib0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0955-0674(02)00375-7","article-title":"Versican: a versatile extracellular matrix proteoglycan in cell biology","volume":"14","author":"Wight","year":"2002","journal-title":"Curr. Opin. Cell Biol."},{"issue":"April (4)","key":"10.1016\/j.prp.2010.10.009_bib0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/44.4.8601689","article-title":"Distribution of the large aggregating proteoglycan versican in adult human tissues","volume":"44","author":"Bode-Lesniewska","year":"1996","journal-title":"J. Histochem. Cytochem."},{"issue":"December (6)","key":"10.1016\/j.prp.2010.10.009_bib0020","first-page":"798","article-title":"Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast","volume":"63","author":"Howeedy","year":"1990","journal-title":"Lab. Invest."},{"issue":"April (2)","key":"10.1016\/j.prp.2010.10.009_bib0025","first-page":"285","article-title":"Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast","volume":"25","author":"Koukoulis","year":"1993","journal-title":"J. Submicrosc. Cytol. Pathol."},{"issue":"June (11)","key":"10.1016\/j.prp.2010.10.009_bib0030","first-page":"3289","article-title":"Changes in tenascin-C isoform expression in invasive and preinvasive breast disease","volume":"62","author":"Adams","year":"2002","journal-title":"Cancer Res."},{"issue":"January (1)","key":"10.1016\/j.prp.2010.10.009_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1026460700592","article-title":"Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M\/versican","volume":"29","author":"Nara","year":"1997","journal-title":"Histochem. J."},{"issue":"April (4)","key":"10.1016\/j.prp.2010.10.009_bib0040","first-page":"1054","article-title":"Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer","volume":"8","author":"Ricciardelli","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"April (7)","key":"10.1016\/j.prp.2010.10.009_bib0045","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1158\/1078-0432.CCR-03-0146","article-title":"Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer","volume":"10","author":"Suwiwat","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2010.10.009_bib0050","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/bcr1751","article-title":"The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis","volume":"9","author":"Yee","year":"2007","journal-title":"Breast Cancer Res."},{"issue":"February (3)","key":"10.1016\/j.prp.2010.10.009_bib0055","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ijc.24812","article-title":"Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting","volume":"126","author":"Kischel","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"October (11)","key":"10.1016\/j.prp.2010.10.009_bib0060","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0959-8049(98)00215-9","article-title":"Expression of tenascin-C in intraductal carcinoma of human breast: relationship to invasion","volume":"34","author":"Jahkola","year":"1998","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2010.10.009_bib0065","first-page":"266","article-title":"Tenascin patterns of expression in duct carcinoma in situ of the breast","volume":"July (30)","author":"Iskaros","year":"2000","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"April (4)","key":"10.1016\/j.prp.2010.10.009_bib0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jcp.56.4.271","article-title":"There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions","volume":"56","author":"Chauhan","year":"2003","journal-title":"J. Clin. Pathol."},{"issue":"March (3)","key":"10.1016\/j.prp.2010.10.009_bib0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s004280100530","article-title":"CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions","volume":"440","author":"Barth","year":"2002","journal-title":"Virchows Arch."},{"issue":"April (8)","key":"10.1016\/j.prp.2010.10.009_bib0080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2407-8-88","article-title":"The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions","volume":"2","author":"Pavlakis","year":"2008","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.prp.2010.10.009_bib0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/bcr580","article-title":"Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast","volume":"5","author":"Shekhar","year":"2003","journal-title":"Breast Cancer Res."},{"issue":"11","key":"10.1016\/j.prp.2010.10.009_bib0090","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.biocel.2007.06.025","article-title":"Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis","volume":"39","author":"Kass","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"January (Pt 2)","key":"10.1016\/j.prp.2010.10.009_bib0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1242\/jcs.040394","article-title":"Integrins in mammary-stem-cell biology and breast-cancer progression \u2013 a role in cancer stem cells?","volume":"122","author":"Pontier","year":"2009","journal-title":"J. Cell Sci."},{"issue":"May (10)","key":"10.1016\/j.prp.2010.10.009_bib0100","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/cncr.21864","article-title":"Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988\u20132001","volume":"106","author":"Li","year":"2006","journal-title":"Cancer"},{"issue":"February (9205)","key":"10.1016\/j.prp.2010.10.009_bib0105","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(99)03703-4","article-title":"Risk of subsequent invasive breast cancer after breast carcinoma in situ","volume":"355","author":"W\u00e4rnberg","year":"2000","journal-title":"Lancet"},{"issue":"January (1)","key":"10.1016\/j.prp.2010.10.009_bib0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.bjc.6602250","article-title":"Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening","volume":"92","author":"Rawal","year":"2005","journal-title":"Br. J. Cancer"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033810002657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033810002657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T03:25:38Z","timestamp":1544066738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033810002657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0344033810002657"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2010.10.009","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}